Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. DEFA14A Proxy Proxy Materials
  2. 8-A12B Other Registration of Securities
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. S-3ASR Offering Registration Statement
  7. ARS Other Annual Report to Security Holders
  8. DEFA14A Proxy Proxy Materials
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. ARS Other Annual Report to Security Holders
  16. DEFA14A Proxy Proxy Materials
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. DEFA14A Proxy Proxy Materials
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. S-3ASR Offering Registration Statement

Page 2 of 3 · 59 filings